Emerald BioStructures has successfully achieved the second milestone in its collaboration with UCB on the structure-based discovery of small molecule modulators of undisclosed targets. Together, the two companies have solved high-resolution X-ray crystallographic structures of multiple targets, and identified unique lead series of small molecules. “Emerald and UCB initiated their collaboration partnership in January of 2009, and over the last 24 months, have made significant progress,” said N...